Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan – (Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan, Published online: 2018-08-29; | doi:10.1038/s41433-018-0192-2)

29 August 2018

This news item is available to RCOphth members only, please log in below to access.